News

Blood levels of neurofilament light chain (NfL), a marker of nerve damage, may help predict the risk of future disease activity and progression in people with multiple sclerosis (MS) who are starting treatment, a study found. However, NfL levels at treatment initiation did not independently…

Thinning of a layer of nerve cells in the retina, the light-sensitive tissue at the back of the eye, was associated with slower information processing in people with multiple sclerosis (MS), independent of physical disability, a study found. Researchers concluded that the findings support retinal imaging as a potential…

In people newly diagnosed with relapsing-remitting multiple sclerosis (MS), a higher number of oligoclonal bands (OCBs) — bands of antibodies found in the fluid surrounding the brain and spinal cord — may reflect more widespread lesions on MRI scans and poorer verbal learning and memory, a study found. “While…

Briumvi (ublituximab-xiiy) may be more effective than Kesimpta (ofatumumab) or Ocrevus (ocrelizumab) at preventing disability progression among people with relapsing forms of multiple sclerosis (MS), according to an indirect comparison of clinical trial data. “In the absence of head-to-head clinical trials, [matching-adjusted indirect comparison] provides a valuable statistical…

Anti-CD20 therapies, a type of treatment approved for multiple sclerosis (MS), may be highly effective in MS partly because they reduce the immune system’s ongoing response to the Epstein-Barr virus (EBV), a well-established risk factor for MS. That’s according to a study involving nearly 200 people that found…

Parental stress may help explain the link between disease-related difficulties and lower self-esteem in children and adolescents with pediatric-onset multiple sclerosis (POMS), a study in Israel found. The findings suggest that higher fatigue, greater disease severity, and slower processing speed in children were each associated with greater parental stress. Greater…

Generic medications are expected to be equivalent to their brand-name counterparts — but a new study found that generic versions of certain treatments for multiple sclerosis (MS) were linked to greater variability in disease biomarkers than the original drugs. “We identified differences in circulating protein biomarker variability between brand…

Scientists at the University of Colorado are testing an experimental approach for multiple sclerosis (MS) that uses electrical stimulation of the vagus nerve to potentially boost the brain’s ability to rewire itself and make rehabilitation more effective. The trial (NCT06641271) is enrolling by invitation at the Clinical…

Scientists have created a “mini-brain” model, the size of a grain of rice, from human stem cells that can mimic multiple sclerosis (MS)-related damage and repair, offering a new avenue for testing drugs that restore the myelin sheath surrounding nerve fibers. The 3D spheroid model contains human nerve cells…

Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in people with progressive forms of multiple sclerosis (MS). Under the agreement, Thermo Fisher’s PPD clinical research business will support…

A brief, personalized neuropsychological rehabilitation program may help people with multiple sclerosis (MS) manage cognitive difficulties, according to a feasibility study. Participants reported improvements in their ability to use cognitive strategies, plan daily activities, and cope with fatigue. The study (ISRCTN11203922) showed that the program, called Neuropsychological Evaluation and…

Higher levels of physical activity may be associated with a lower likelihood of developing multiple sclerosis (MS), mainly among people with low sun exposure, a Swedish study suggests. The study assessed leisure-time physical activity and sun exposure. In the overall population, no clear overall association was found between physical…

Adding probiotics to standard multiple sclerosis (MS) therapies may help to reduce fatigue, depression, and disability levels, as well as improve quality of life, in people with relapsing-remitting MS (RRMS), according to data from a small clinical trial. Probiotics are live microorganisms intended to support health. Compared with patients…

A fast-track diagnostic pathway that includes a specific MRI marker called the central vein sign (CVS) cut the average time to diagnose multiple sclerosis (MS) by about three months compared with the usual outpatient route, according to a hospital review. It also eliminated the need for invasive lumbar punctures,…

Altered neurovascular coupling (NVC), the process that matches brain activity with the blood flow needed to support it, is associated with poorer cognitive function and greater disability in people with multiple sclerosis (MS), a study found. The most consistent finding was an abnormal balance between blood flow and spontaneous…

The U.S. Food and Drug Administration (FDA) has agreed to review an application from Roche seeking approval of its BTK inhibitor fenebrutinib as a treatment for relapsing forms of both multiple sclerosis (MS) and primary progressive MS (PPMS). Further, the FDA granted the application priority review, under…

An estimated 3.1 million people worldwide are now living with multiple sclerosis (MS), up from about 2.8 million in 2020, according to the latest update of the Multiple Sclerosis International Federation’s Atlas of MS. The new estimate means that global MS prevalence — the number of people living…

An experimental therapy called kamuvudine-9 (K-9) reversed established paralysis and vision loss in a mouse model of multiple sclerosis (MS), offering hope for treatments that can restore lost function rather than just prevent future damage. “Most MS therapies are aimed at preventing the next attack. What’s remarkable is…

A digital lifestyle program promoting a balanced diet, regular physical activity, better sleep, and stress management was associated with improvements in several measures and behaviors reported by people with multiple sclerosis (MS), a study found. Most gains emerged during the intensive three-month program. Over the next 21 months, improvements…

Higher blood levels of neurofilament light chain (NfL), a well-established marker of nerve damage, are associated with lower daily activity in people with progressive forms of multiple sclerosis (MS), a study found. The study also demonstrated that patients in whom NfL levels increased more rapidly over time tended to…

A high-fat diet may lead to worse disability in people with multiple sclerosis (MS) by altering the composition of gut bacteria, leading to changes in the number of immune cells that enter the brain, a study in mice suggests. According to the researchers, these findings show how a diet…

Prior infection with the cytomegalovirus (CMV), a type of herpesvirus, was associated with lower odds of developing multiple sclerosis (MS), while herpes simplex virus (HSV) infection showed no significant association with the disease. That’s according to a study involving data from more than 320,000 individuals in Israel that also…

A specialized MRI technique detected signs of myelin and iron loss in nerve fibers beneath the brain’s outer layer in people with relapsing-remitting multiple sclerosis (RRMS), but not in those with a related disease, called neuromyelitis optica spectrum disorder (NMOSD). That’s according to a study in China that also…

Breathing problems are common in advanced multiple sclerosis (MS), becoming more frequent as disability increases, according to a study by researchers in London. “Screening for respiratory dysfunction can be easily incorporated into routine clinical care by asking about respiratory symptoms,” they wrote. The study, “Respiratory dysfunction in people…

Researchers have identified four key biomarkers in the fluid surrounding the brain and spinal cord that may be used to assess response to MSC-NP, a type of stem cell therapy currently in early clinical testing for progressive forms of multiple sclerosis (MS). The levels of these four molecules —…

Regulators in the European Union (EU) have recommended that the infusion therapy Ocrevus (ocrelizumab) be approved to treat children and teens, ages 10 and older, who have relapsing forms of multiple sclerosis (MS). The recommendation comes from the Committee for Medicinal Products for Human Use (CHMP), an arm…

Tiziana Life Sciences has signed a deal with strategic partners to support a clinical trial designed to test its experimental nasal therapy foralumab in people with hard-to-treat relapsing-remitting multiple sclerosis (RRMS). Under the signed Memorandum of Understanding (MOU), the collaboration involves Tiziana, The King Abdullah International Medical Research…

Among people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with higher depression severity, according to a small study from Egypt. The study showed that people with RRMS had substantially higher rates of at least moderate depression than people without multiple sclerosis (MS). More severe depression was also…